Pacira BioSciences, Inc. (PCRX)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 778,348 749,583 879,278 892,162 870,130 831,551 807,975 768,041 775,010 770,123 756,636 709,576 730,408 718,602 687,168 650,818 619,688 584,690 388,148 374,037
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $778,348K)
= 0.00

The debt-to-capital ratio of Pacira BioSciences, Inc. has consistently been recorded as 0.00 across all quarters from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized debt as a significant portion of its capital structure during this period. A debt-to-capital ratio of 0.00 signifies that the company's total debt is either very low or non-existent compared to its total capital, which includes both debt and equity. This data suggests that Pacira BioSciences has been relying more on equity financing rather than debt financing to fund its operations and investments. It also indicates a relatively low financial risk associated with debt obligations, as debt levels are minimal or negligible in relation to the company's capital base.